Abstracts Archive - Page 206 of 1683 - ATC Abstracts

2021 American Transplant Congress
Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience
J. Ferrer-Fàbrega¹, R. Muñoz², J. Ruiz³, D. Casanova⁴, F. Sánchez-Bueno⁵, J. Pérez-Daga⁶, C. Fernández-Rivera⁷, M. Gómez⁸, F. Castillo⁹, R. López-Andújar¹⁰, J. Maupoey¹⁰, J. Briceño¹¹, J. Sánchez-Hidalgo¹¹, Á. Arjona¹¹, A. Álvarez¹², A. Alarcó¹³, A. Bravo¹³, R. García¹, R. Rull¹, M. López-Boado¹, P. Ventura-Aguiar¹⁴, F. Diekmann¹⁴, D. Paredes¹⁵, J. García-Valdecasas¹, J. Fuster¹, C. Fondevila¹, B. Domínguez-Gil²
¹Hepatobiliopancreatic Surgery and Transplantation Department, Hospital Clínic Barcelona, Barcelona, Spain, ²Organización Nacional de Trasplantes (ONT), Madrid, Spain, ³Department of Nephrology., University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ⁴Department of Surgery, University Hospital Marques de Valdecilla, University Cantabria, Santander., Santander, Spain, ⁵Department of General, Visceral and Transplantation Surgery., Clinic and University Hospital Virgen de la Arrixaca. IMIB-ARRIXACA. Murcia., Murcia, Spain, ⁶Department of Surgery, Hospital Regional de Málaga. Málaga., Málaga, Spain, ⁷Department of Nephrology., Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁸Department of Surgery, Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁹Department of Surgery, University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ¹⁰Hepato-Pancreatico-Biliary Surgery and Transplant Unit, La Fe University Hospital. Valencia, Valencia, Spain, ¹¹Department of Surgery, Hospital Universitario Reina Sofía. Córdoba, Córdoba, Spain, ¹²Department of Nephrology., Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹³Department of Surgery, Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹⁴Renal Transplant Unit, Hospital Clínic Barcelona, Barcelona, Spain, ¹⁵Coordination Department, Hospital Clínic Barcelona, Barcelona, Spain
*Purpose: To report on the Spanish Pancreas Transplantation experience in controlled donation after circulatory death (cDCD) by analyzing the normothermic regional perfusion (NRP) and super-rapid…
2021 American Transplant Congress
The Calculated Panel of Incompatible Epitopes (cPIE) in the Service of Equitable Access to Transplantation
J. Lamsatfi¹, B. Bingfan Liu¹, S. Parto², A. Lewin³, K. Oualkacha¹, F. Claas⁴, P. Keown⁵, R. Sapir-Pichhadze⁶
¹McGill University, Montreal, QC, Canada, ²McGill University Health Centre, Montreal, QC, Canada, ³Hema-Quebec, Montreal, QC, Canada, ⁴Leiden University Medical Centre, Albinusdreef, Netherlands, ⁵University of British Columbia, Vancouver, BC, Canada, ⁶Medicine, McGill University Health Centre, Montreal, QC, Canada
*Purpose: To inform on feasibility of eplet matching, we developed the calculated Panel of Incompatible Epitopes (cPIE), an algorithm informing on the likelihood of identifying…
2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…
2021 American Transplant Congress
Kidney Transplant Biopsy Findings After Covid-19
E. Daniel¹, S. Kudose², D. J. Cohen¹, L. Ratner³, V. D'Agati², I. Batal²
¹Division of Nephrology, Columbia University Medical Center, NY, NY, ²Department of Pathology, Columbia University Medical Center, NY, NY, ³Department of Surgery, Columbia University Medical Center, NY, NY
*Purpose: COVID-19 has been reported as a cause of kidney injury and data from published native kidney biopsy results demonstrate a variety of causes. To…
2021 American Transplant Congress
Induction in Pancreas Transplantation: T-Cell Depletion vs. Il-2 Receptor Blockade
F. Aziz, S. Parajuli, D. Kaufman, J. Odorico, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: There are limited data comparing outcomes with different induction agents in pancreas transplantation. In this study, we compare T-cell depletion to IL-2 receptor (IL2R)…
2021 American Transplant Congress
One-Year Monitoring of Changes to Kidney-Pancreas Waiting Time Criteria: An OPTN Analysis
R. C. Forbes¹, B. Plucinski², J. White², N. T. Kyaw², R. Kandaswamy³, S. V. Niederhaus⁴
¹Surgery, Vanderbilt University, Nashville, TN, ²UNOS, Richmond, VA, ³Surgery, University of Minnesota, Minneapolis, MN, ⁴Surgery, University of Maryland, Baltimore, MD
*Purpose: In 2018, the OPTN board approved changes to kidney-pancreas (KP) waiting time criteria. KP candidates accrued waiting time if they were (1) on insulin…
2021 American Transplant Congress
Systematic Evaluation of Immunosuppressant Drug Tolerability in Lung Transplant Recipients with Short Telomere Syndrome
R. Patolia¹, R. Guzy², L. Potter¹
¹Department of Pharmacy, University of Chicago Medicine, Chicago, IL, ²Department of Medicine, Division of Pulmonology, University of Chicago Medicine, Chicago, IL
*Purpose: Lung transplant recipients with short telomere syndrome are at high risk of hematologic complications. Consequently, patients with short telomere syndrome may require more frequent…
2021 American Transplant Congress
Donor Derived Cell-Free DNA (dd-cfDNA) in Pancreas Transplant Recipients
S. Riad¹, H. Sarumi², R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota Physicians, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Data on the role of DD-cfDNA after pancreas transplantation is lacking. Herein we report on our center experience with DD-cfDNA in 10 unique SPK…
2021 American Transplant Congress
Donor-Derived Cell-Free DNA Can Differentiate Rejection versus Other Causes of Pancreas Transplant Dysfunction
N. Ali¹, J. Miles², Z. Stewart Lewis¹
¹Transplant Institute, NYU Langone Health, New York, NY, ²CareDx, Brisbane, CA
*Purpose: Assessment and early detection of allograft injury in simultaneous pancreas and kidney (SPK) transplant recipients has clear benefits for optimizing treatment and intervention. Donor-derived…
2021 American Transplant Congress
Endocrine Cell Identity and HOMA-B In Patients with Chronic Pancreatitis Undergoing Islet Auto-transplantation
C. A. Beamish¹, O. Gaber², O. M. Sabek²
¹Surgery, Houston Mehodist Hospital, Houston, TX, ²Surgery, Houston Mehodist, Houston, TX
*Purpose: Islet identity loss is an emergent factor in dysglycemia in diabetes, islet transplantation, and chronic pancreatitis (CP). Pancreatectomy and islet auto-transplantation (PIAT) for CP…